em-tec GmbH – Trademark Portfolio
Entity Type: 99
em-tec GmbH holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include BIOPROTT. The owner is based in Finning.
Lerchenberg 20
Finning 86923 , DE
Showing of trademarks Trademarks
Trademark Classifications
em-tec GmbH's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does em-tec GmbH have?
em-tec GmbH has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending, 1 abandoned, 1 cancelled.
What trademark classes does em-tec GmbH file in?
em-tec GmbH files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are em-tec GmbH's most well-known trademarks?
em-tec GmbH's registered trademark portfolio includes well-known marks such as BIOPROTT. These are among 1 currently registered trademark in the portfolio.
What is em-tec GmbH's trademark registration success rate?
em-tec GmbH has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 3 applications are pending review.